Eczema

Skincare Mondays | Improving Quality of Life for Eczema Patients
eczemaAtopic dermatitis (AD) is a chronic skin condition characterized by pruritus, inflammation, and acute flare-ups of eczematous lesions over dry skin.1 The wide range of clinical manifestations, the visible nature of the disease, and the intense itching significantly affects patients’ quality of life.2  Up to 80% of children with AD experience sleep disturbances.3 Sixty-seven percent of children …
eczema
COLLOIDAL OATMEAL CHEAT SHEET
colloidal oatmealOatmeal has been used as a skin care ingredient since 2000 BC in ancient Egypt, where whole oats were used in soothing baths. Colloidal oat has been the subject of dedicated skin care research starting in the 1950s. After > 30 clinical studies comprised of over 3000 patients including conditions associated with a compromised skin barrier, colloidal oat is now recognized as a skin protectant by …
colloidal oatmeal
Atopic Dermatitis (AD) Treatment Initiation and Monitoring
atopic dermatitis (AD)During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. This article provides a summary of their discussion and recommendations.  CASE 1 51-year-old male with a 20-year history of AD. The patient was first seen in September 2015 with BSA …
atopic dermatitis (AD)
Tralokinumab-ldrm Therapeutic Cheat Sheet
tralokinumabAtopic dermatitis is a common, chronic, life-altering disease. With its visibility and debilitating pruritus, atopic dermatitis significantly impacts our patients’ quality of life. For those with resistant and extensive disease, we are happy to have numerous new systemic agents at our disposal, one being tralokinumab, an IL-13 antagonist. We continue our series, Therapeutic Cheat Sheet, with a c …
tralokinumab
Skincare Mondays | Data-Driven Dermatology Improves Patient Outcomes
data driven dermatologyData-Driven Dermatology Improves Patient Outcomes The use of real-world data and real-world evidence to inform health care decisions is increasing. While randomized controlled trials (RCTs) are still the gold standard for evidence-based medicine, the strict inclusion/exclusion criteria and tightly controlled conditions limit their generalizability to real-world clinical practice.  Real worl …
data driven dermatology